Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Inès Raoelfils"'
Autor:
Praagh-Doreau I Van, Emilie Thivat, Qian Wang-Lopez, Inès Raoelfils, Catherine Abrial, Frédérique Penault-Llorca, J-M Nabholtz, M-A Mouret-Reynier, P. Chollet, Xavier Durando, P. Gimbergues
Publikováno v:
Cancer Research. 71:P5-14
Purpose of the study: In a new database harbouring the patients of several prospective phase II neoadjuvant trials (fec 50–100, net, tncf, taxotere/tncf, taxotere alone), the predictive value of tumour factors (SBR grade, RH, Her2, Ki-67 and cyclin
Autor:
Frédérique Penault-Llorca, B. Aublet-Cuvelier, Anne Cayre, Gautier Chene, Christophe Pomel, Inès Raoelfils, P. Jaffeux, Jacques Dauplat, Yves-Jean Bignon
Publikováno v:
Annales de Pathologie. 31:3-10
Resume Introduction L’analyse meticuleuse histopathologique des pieces d’ovariectomies prophylactiques realisees en cas de risque genetique avere (mutation BRCA) ou de predisposition hereditaire (lourds antecedents familiaux) peut reveler des ano
Autor:
Hervé Curé, Jean-Louis Achard, Catherine Abrial, Xavier Durando, Philippe Chollet, Olivier Tacca, Pierre Gimbergues, Inès Raoelfils, Marie-Ange Mouret-Reynier, Frédérique Penault-Llorca
Publikováno v:
The oncologist. 12(6)
The aim of this study was to detect and analyze changes in hormone receptor (HR) status after treatment of operable breast cancer with neoadjuvant chemotherapy (NCT). Patients were treated from 1982 to 2004 with different NCT combinations, mainly in
Autor:
Jean-Louis Achard, P. Gimbergues, Catherine Abrial, Marianne Leheurteur, Anne Cayre, Xavier Durando, Philippe Chollet, Inès Raoelfils, Marie-Ange Mouret-Reynier, Frédérique Penault-Llorca
Publikováno v:
Human pathology. 39(8)
Pathologic complete response (pCR) is linked to a better outcome, but its definition varies among working groups. We performed this study to validate different expressions of pCR as well as to determine the role of in situ and isolated tumor cell res
Autor:
Frédérique Penault-Llorca, Marianne Leheurteur, Philippe Chollet, Catherine Abrial, Inès Raoelfils, Marie-Ange Mouret-Reynier, Xavier Durando, Hervé Curé, P. Gimbergues, Jacques Tortochaux
Publikováno v:
The oncologist. 12(4)
Recent trials of induction chemotherapy in bulky operable breast cancer have shown much higher pathological complete response (pCR) rates with trastuzumab-driven combinations. However, it is useful to take into account the specific chemosensitivity o
Autor:
Catherine, Abrial, Florence, Bouchet-Mishellany, Inès, Raoelfils, Anne, Cayre, Hervé, Curé, Philippe, Chollet, Frédérique, Penault-Llorca
Publikováno v:
Bulletin du cancer. 93(7)
The pathologist plays a key role in the optimal management of patients receiving an induction or a neoadjuvant chemotherapy. The evaluation of the pre-treatment biopsy helps to establish key patient-management parameters such as tumor type, SBR grade
Autor:
S.A. Brahmi, C. Abrial, P. Dubray, P. Chollet, Jean-Marc Nabholtz, B. Nayl, Inès Raoelfils, Marie-Ange Mouret-Reynier, Frédérique Penault-Llorca, I. Van Praag
Publikováno v:
European Journal of Cancer. 47:S345-S346
Autor:
Aicha Goubar, Veronique Verrielle, Fabrice Andre, Henri Roché, Anne-Laure Martin, Jocelyne Jacquemier, Yves Denoux, Frédérique Penault-Llorca, Christine Sagan, Inès Raoelfils, Magali Lacroix-Triki
Publikováno v:
Journal of Clinical Oncology. 30:543-543
543 Background: Several reports suggest an inter-observer variability in Ki67 assessment. Nevertheless, there is no large study that evaluates the rate of discrepancies, together with their impact. Methods: Ki67 expression was assessed on 663 samples
Autor:
Christian Garbar, Jean-Christophe Eymard, Xavier Durando, M.-A. Mouret-Reynier, P. Chollet, Hervé Curé, E. Brabencova, Jean-Marc Nabholtz, J. Charpentier, Christelle Jouannaud, Inès Raoelfils, Frédérique Penault-Llorca, Qian Wang-Lopez
Publikováno v:
Journal of Clinical Oncology. 29:1133-1133
1133 Background: Achieving pathologic complete response (pCR) is the main goal in NACT. PCR rates will be studied comparatively for stage II-IIIA operable breast cancer in 264 women, randomized to receive either 3 FEC 100 then 3 docetaxel 100 mg/m2 (
Autor:
Frédérique Penault-Llorca, Yves Communal, Sandrine Viala, Gautier Chene, Yannick Bidet, Yves-Jean Bignon, Nancy Uhrhammer, Inès Raoelfils
Publikováno v:
Cancer Research. 71:4854-4854
Ovarian malignancies may arise through different mechanisms of oncogenesis, which influence their treatment and are important for prognosis. Essential to carcinogenesis is the activation of proliferation pathways such as those directed by PI3 kinase